PRICE T ROWE ASSOCIATES INC /MD/ - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$751
-24.9%
46,791
+8.5%
0.00%
Q2 2023$1,000
+5.6%
43,139
+5.9%
0.00%
Q1 2023$947
+65.0%
40,734
+2.9%
0.00%
Q4 2022$574
-99.9%
39,571
+2.8%
0.00%
Q3 2022$735,000
+21.3%
38,494
+15.5%
0.00%
Q2 2022$606,000
-26.7%
33,334
+1.6%
0.00%
Q1 2022$827,000
-6.0%
32,825
+2.9%
0.00%
Q4 2021$880,000
-21.7%
31,902
-8.4%
0.00%
Q3 2021$1,124,000
+5.8%
34,821
+0.3%
0.00%
Q2 2021$1,062,000
+17.2%
34,721
+16.7%
0.00%
Q1 2021$906,000
+11.9%
29,757
-27.4%
0.00%
Q4 2020$810,000
+10.5%
40,978
-27.1%
0.00%
Q3 2020$733,000
+15.1%
56,1830.0%0.00%
Q2 2020$637,000
-19.9%
56,183
+1.2%
0.00%
Q1 2020$795,000
-47.0%
55,542
+0.7%
0.00%
Q4 2019$1,501,000
+62.8%
55,132
+71.3%
0.00%
Q3 2019$922,000
+4.2%
32,190
+1.1%
0.00%
Q2 2019$885,000
-15.8%
31,842
+0.5%
0.00%
Q1 2019$1,051,000
+16.6%
31,669
+2.2%
0.00%
Q4 2018$901,000
-19.3%
30,999
+27.8%
0.00%
Q3 2018$1,116,000
+23.0%
24,253
-0.1%
0.00%
Q2 2018$907,000
+26.9%
24,271
+0.3%
0.00%
Q1 2018$715,000
-13.5%
24,195
+0.5%
0.00%
Q4 2017$827,000
-23.5%
24,068
-19.5%
0.00%
Q3 2017$1,081,000
+40.0%
29,8880.0%0.00%
Q2 2017$772,000
+34.5%
29,8880.0%0.00%
Q1 2017$574,000
+15.3%
29,888
+0.0%
0.00%
Q4 2016$498,000
-19.0%
29,8800.0%0.00%
Q3 2016$615,000
+9.4%
29,880
+62.6%
0.00%
Q2 2016$562,000
-30.4%
18,380
-14.8%
0.00%
Q1 2016$808,000
+12.2%
21,580
+29.4%
0.00%
Q4 2015$720,000
+35.3%
16,680
+17.5%
0.00%
Q3 2015$532,000
-36.4%
14,200
-42.3%
0.00%
Q2 2015$836,000
-81.5%
24,590
-80.7%
0.00%
-100.0%
Q1 2015$4,517,000
+3.9%
127,6000.0%0.00%0.0%
Q4 2014$4,346,000
-11.7%
127,6000.0%0.00%0.0%
Q3 2014$4,922,000
-0.9%
127,6000.0%0.00%0.0%
Q2 2014$4,966,000
+15.6%
127,600
+1.6%
0.00%0.0%
Q1 2014$4,294,000
-19.0%
125,600
-50.3%
0.00%0.0%
Q4 2013$5,304,000
+74.7%
252,800
+95.7%
0.00%0.0%
Q3 2013$3,036,000
-55.9%
129,200
-49.6%
0.00%0.0%
Q2 2013$6,890,000256,4000.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders